Edgar Lomax Co. VA Sells 65,585 Shares of MetLife, Inc. $MET

Edgar Lomax Co. VA lessened its position in shares of MetLife, Inc. (NYSE:MET) by 22.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 224,415 shares of the financial services provider’s stock after selling 65,585 shares during the period. MetLife makes up about 1.4% of Edgar Lomax Co. VA’s holdings, making the stock its 28th biggest position. Edgar Lomax Co. VA’s holdings in MetLife were worth $18,485,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the company. Evolution Wealth Management Inc. purchased a new stake in shares of MetLife in the second quarter worth $35,000. Salomon & Ludwin LLC increased its stake in MetLife by 95.4% in the 3rd quarter. Salomon & Ludwin LLC now owns 422 shares of the financial services provider’s stock worth $35,000 after acquiring an additional 206 shares during the last quarter. True Wealth Design LLC raised its holdings in shares of MetLife by 564.1% in the 3rd quarter. True Wealth Design LLC now owns 425 shares of the financial services provider’s stock valued at $35,000 after acquiring an additional 361 shares in the last quarter. MTM Investment Management LLC bought a new stake in shares of MetLife during the 2nd quarter valued at about $37,000. Finally, Dunhill Financial LLC grew its holdings in shares of MetLife by 413.2% during the third quarter. Dunhill Financial LLC now owns 467 shares of the financial services provider’s stock worth $38,000 after purchasing an additional 376 shares in the last quarter. 94.99% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the stock. UBS Group raised their target price on shares of MetLife from $94.00 to $98.00 and gave the company a “buy” rating in a research note on Thursday, February 5th. Mizuho set a $100.00 price objective on shares of MetLife in a research report on Thursday, February 12th. Morgan Stanley dropped their price objective on shares of MetLife from $101.00 to $93.00 and set an “overweight” rating for the company in a report on Tuesday. Wells Fargo & Company reduced their target price on MetLife from $97.00 to $93.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 25th. Finally, Evercore set a $95.00 price target on MetLife in a research note on Tuesday, February 10th. Two investment analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, MetLife presently has a consensus rating of “Buy” and an average price target of $94.18.

MetLife Price Performance

Shares of NYSE:MET opened at $72.88 on Friday. The company’s fifty day moving average is $77.37 and its 200 day moving average is $78.76. The company has a quick ratio of 0.20, a current ratio of 0.20 and a debt-to-equity ratio of 0.52. MetLife, Inc. has a 52 week low of $65.21 and a 52 week high of $85.00. The stock has a market cap of $47.52 billion, a PE ratio of 15.51, a PEG ratio of 0.67 and a beta of 0.76.

MetLife (NYSE:MET) last released its quarterly earnings data on Wednesday, February 4th. The financial services provider reported $2.49 EPS for the quarter, topping the consensus estimate of $2.34 by $0.15. The firm had revenue of $52.44 billion for the quarter, compared to the consensus estimate of $31.43 billion. MetLife had a return on equity of 21.81% and a net margin of 4.38%.The company’s quarterly revenue was up 27.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.08 earnings per share. Research analysts anticipate that MetLife, Inc. will post 9.65 earnings per share for the current year.

MetLife Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 10th. Shareholders of record on Tuesday, February 3rd will be given a $0.5675 dividend. The ex-dividend date is Tuesday, February 3rd. This represents a $2.27 annualized dividend and a yield of 3.1%. MetLife’s payout ratio is presently 48.30%.

Key MetLife News

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: MetLife confirmed its previously announced first-quarter 2026 dividend on its Series A floating-rate preferred shares, providing near-term cash-return certainty for preferred holders and removing dividend timing uncertainty. Article Title
• Positive Sentiment: Brokerage coverage remains constructive: a recent note shows MetLife has an average analyst rating of “Buy,” which supports medium-term demand for the stock. Article Title
• Neutral Sentiment: MetLife GCC signed a lease for ~75,000 sq ft in Noida, India — a corporate office move that signals regional investment but is unlikely to materially affect near-term earnings. Article Title
• Neutral Sentiment: MetLife and Crow Holdings completed a trade of 210 multifamily units in Tampa — a routine portfolio transaction that reflects active asset management in its real assets business. Article Title
• Neutral Sentiment: Management presented at the Raymond James institutional investor conference; the transcript provides updated posture on capital deployment and strategy but contained no market-moving surprises. Article Title
• Neutral Sentiment: Media coverage around MetLife Stadium (World Cup match hosting, team training-camp talk) boosts brand visibility but has limited direct impact on insurance fundamentals. Article Title
• Negative Sentiment: Morgan Stanley published a pessimistic forecast on MET stock, which can pressure sentiment and weigh on the share price despite the company’s earnings beat earlier in February. Article Title

About MetLife

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.